Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a: Modelling the Clinical and Economic Implications

Author: Guo Shien   Bozkaya Duygu  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.27, Iss.1, 2009-01, pp. : 39-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract